Literature DB >> 32659280

Direct Versus Indirect Corneal Neurotization for the Treatment of Neurotrophic Keratopathy: A Multicenter Prospective Comparative Study.

Paolo Fogagnolo1, Giuseppe Giannaccare2, Federico Bolognesi3, Maurizio Digiuni1, Laura Tranchina1, Luca Rossetti1, Angelica Dipinto4, Fabiana Allevi5, Alessandro Lozza6, Dimitri Rabbiosi5, Silvia Mariani7, Marco Pellegrini7, Federica E Cazzola8, Simone Bagaglia9, Cosimo Mazzotta9, Guido Gabriele10, Paolo Gennaro10, Giovanni Badiali3, Claudio Marchetti3, Emilio C Campos7, Federico Biglioli5.   

Abstract

PURPOSE: To analyze the comparative safety and efficacy of two techniques of corneal neurotization (CN) (direct corneal neurotization [DCN] vs indirect corneal neurotization [ICN]) for the treatment of neurotrophic keratopathy (NK).
DESIGN: Multicenter interventional prospective comparative case series.
METHODS: This study took place at ASST Santi Paolo e Carlo University Hospital, Milan; S.Orsola-Malpighi University Hospital, Bologna; and Santa Maria alle Scotte University Hospital, Siena, Italy. The study population consisted of consecutive patients with NK who underwent CN between November 2014 and October 2019. The intervention procedures included DCN, which was was performed by transferring contralateral supraorbital and supratrochlear nerves. ICN was performed using a sural nerve graft. The main outcome measures included NK healing, corneal sensitivity, corneal nerve fiber length (CNFL) measured by in vivo confocal microscopy (IVCM), and complication rates.
RESULTS: A total of 26 eyes in 25 patients were included: 16 eyes were treated with DCN and 10 with ICN. After surgery, NK was healed in all patients after a mean period of 3.9 months without differences between DCN and ICN. Mean corneal sensitivity improved significantly 1 year after surgery (from 3.07 to 22.11 mm; P < .001) without differences between the 2 groups. The corneal sub-basal nerve plexus that was absent before surgery in all patients, except 4, become detectable in all cases (mean CNFL: 14.67 ± 7.92 mm/mm2 1 year postoperatively). No major complications were recorded in both groups.
CONCLUSIONS: CN allowed the healing of NK in all patients as well as improvement of corneal sensitivity in most of them thanks to nerve regeneration documented by IVCM. One year postoperatively, DCN and ICN showed comparable outcomes.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2020        PMID: 32659280     DOI: 10.1016/j.ajo.2020.07.003

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  10 in total

Review 1.  Corneal neurotization for neurotrophic keratopathy: Review of surgical techniques and outcomes.

Authors:  Catherine Y Liu; Andrea C Arteaga; Sammie E Fung; M Soledad Cortina; Ilya M Leyngold; Vinay K Aakalu
Journal:  Ocul Surf       Date:  2021-02-26       Impact factor: 5.033

Review 2.  Regenerative therapy for the Cornea.

Authors:  Ajay Kumar; Hongmin Yun; Martha L Funderburgh; Yiqin Du
Journal:  Prog Retin Eye Res       Date:  2021-09-14       Impact factor: 21.198

3.  Minimally invasive, indirect corneal neurotization using an ipsilateral sural nerve graft for early neurotrophic keratopathy.

Authors:  Brendon W H Lee; Muhammad A Khan; Quan D Ngo; Krishna Tumuluri; Chameen Samarawickrama
Journal:  Am J Ophthalmol Case Rep       Date:  2022-05-20

4.  Validation of a Cleanroom Compliant Sonication-Based Decellularization Technique: A New Concept in Nerve Allograft Production.

Authors:  Federico Bolognesi; Nicola Fazio; Filippo Boriani; Viscardo Paolo Fabbri; Davide Gravina; Francesca Alice Pedrini; Nicoletta Zini; Michelina Greco; Michela Paolucci; Maria Carla Re; Sofia Asioli; Maria Pia Foschini; Antonietta D'Errico; Nicola Baldini; Claudio Marchetti
Journal:  Int J Mol Sci       Date:  2022-01-28       Impact factor: 5.923

5.  Maternal serum eye drops to treat bilateral neurotrophic keratopathy in congenital corneal anesthesia: Case report and literature review.

Authors:  Giuseppe Giannaccare; Andrea Lucisano; Marco Pellegrini; Gianfranco Scuteri; Alessandra Mancini; Cristina Malaventura; Massimo Busin; Vincenzo Scorcia
Journal:  Am J Ophthalmol Case Rep       Date:  2022-02-18

Review 6.  New Pharmacological Approaches for the Treatment of Neurotrophic Keratitis.

Authors:  Su Yin Koay; Daniel F P Larkin
Journal:  Front Pharmacol       Date:  2022-03-22       Impact factor: 5.810

7.  Commentary: Corneal neurotization.

Authors:  Sridevi Nair; Manpreet Kaur; Jeewan S Titiyal
Journal:  Indian J Ophthalmol       Date:  2022-06       Impact factor: 2.969

Review 8.  Neurotization of the human cornea - A comprehensive review and an interim report.

Authors:  Anubha Rathi; Nandini Bothra; Smruti R Priyadarshini; Divya S R Achanta; Merle Fernandes; Somasheila I Murthy; Anasua G Kapoor; Tarjani V Dave; Suryasnata Rath; Rajesh Yellinedi; Rambabu Nuvvula; Gautam Dendukuri; Milind N Naik; Muralidhar Ramappa
Journal:  Indian J Ophthalmol       Date:  2022-06       Impact factor: 2.969

9.  Functional and Structural Changes Following Corneal Neurotisation in the Management of Neurotrophic Keratopathy: UK Single Centre Series.

Authors:  Mohamed Elalfy; Sundas Maqsood; Scott Hau; Ruben Y Kannan; Charles Nduka; Samer Hamada; Raman Malhotra
Journal:  Clin Ophthalmol       Date:  2021-05-24

10.  Topical citicoline and vitamin B12 versus placebo in the treatment of diabetes-related corneal nerve damage: a randomized double-blind controlled trial.

Authors:  Paolo Fogagnolo; Ettore Melardi; Laura Tranchina; Luca Rossetti
Journal:  BMC Ophthalmol       Date:  2020-08-01       Impact factor: 2.209

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.